false
0001787518
0001787518
2025-11-06
2025-11-06
0001787518
NUKK:CommonStock0.0001ParValuePerShareMember
2025-11-06
2025-11-06
0001787518
NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember
2025-11-06
2025-11-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 6, 2025
NUKKLEUS INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-39341 |
|
38-3912845 |
(State or other jurisdiction of
incorporation or organization) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
575 Fifth Avenue, 14th Floor
New York, New York 10017
(Address of principal executive offices)
212-791-4663
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.0001 par value per share |
|
NUKK |
|
The Nasdaq Stock Market LLC |
| |
|
|
|
|
| Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share |
|
NUKKW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of
Security Holders.
On November 6, 2025, Nukkleus
Inc. (the “Company”) completed its 2025 annual meeting of stockholders (the “Annual Meeting”). The number of shares
of common stock, $0.0001 par value per share (the “Common Stock”), entitled to vote at the Annual Meeting was 13,550,766 shares.
The number of shares of Common Stock present or represented by valid proxy at the Annual Meeting was 5,135,897 shares of Common Stock,
representing a quorum. The following actions were taken at the Annual Meeting:
Proposal No. 1: Election of Directors
The first proposal was the
election of five (5) directors each to serve until the next annual meeting of stockholders and until their successors are duly elected
and qualified or until his or her earlier resignation or removal or otherwise is disqualified from serving as a director of the Company.
The vote on the proposal was as follows:
| Name of Nominee |
|
FOR |
|
WITHHELD |
|
BROKER
NON-VOTE |
| Menachem Shalom |
|
5,125,178 |
|
10,719 |
|
0 |
| David Rokach |
|
4,928,925 |
|
206,972 |
|
0 |
| Tomer Nagar |
|
5,119,057 |
|
16,840 |
|
0 |
| Aviva Volodarsky |
|
5,041,814 |
|
94,083 |
|
0 |
| Reuven Yeganeh |
|
5,041,088 |
|
94,809 |
|
0 |
Each nominee was elected.
Proposal No. 2: Ratification of the Appointment of Independent External
Auditors
The second proposal was the
ratification of the appointment of Somekh Chaikin, a member firm of KPMG International, as the Company’s independent external auditors
for the year ending December 31, 2025. The vote on the proposal was as follows:
| FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTE |
| 5,120,639 |
|
10,837 |
|
4,421 |
|
0 |
Proposal
No. 2 was approved by a majority of shares of Common Stock present in person or by proxy at the Annual Meeting.
Proposal No. 3: Approval and Adoption of the
2025 Equity Incentive Plan and Authorization of 3,950,000 Shares of Common Stock for Issuance Thereunder
The third proposal was the
approval and adoption of the Company’s 2025 Equity Incentive Plan and the authorization of 3,950,000 shares of Common Stock for
issuance under the 2025 Equity Incentive Plan. The vote on the proposal was as follows:
| FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTE |
| 4,830,626 |
|
302,091 |
|
3,180 |
|
0 |
Proposal No. 3 was approved
by a majority of shares of Common Stock present in person or by proxy at the Annual Meeting.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
NUKKLEUS INC. |
| |
|
|
| Date: November 10, 2025 |
By: |
/s/ Menachem Shalom |
| |
Name: |
Menachem Shalom |
| |
Title: |
Chief Executive Officer |
2